<DOC>
	<DOCNO>NCT00824460</DOCNO>
	<brief_summary>The purpose study investigate ability different dos PA21 low serum phosphate level , patient chronic kidney disease maintenance hemodialysis .</brief_summary>
	<brief_title>Study Phosphate Levels Patients With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>Main â‰¥ 18 year age , Receiving stable maintenance hemodialysis 3 time week On restricted phosphate diet screen throughout study Receiving stable dose phosphate binder least 1 month Serum phosphate level &gt; 1.78 mmol/L Main Uncontrolled hyperphosphatemia Hypercalcemia screen washout Serum calcium &lt; 1.9 mmol/L ( &lt; 7.6 mg/dL ) Severe hyperparathyroidism ( iPTH level &gt; 600 ng/L ) Pregnancy lactation Iron deficiency anemia History hemochromatosis ferritin &gt; 800 mg/L , Hepatitis B , hepatitis C significant concurrent liver disorder Known positivity HIV Use oral iron preparation 1 month screening , Serious medical condition uncontrolled systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hemodialysis</keyword>
</DOC>